Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In the early ...

COVID-19 has become less of an urgent threat than it was in 2019 largely because of vaccines and growing immunity from natural infections, but antiviral treatments have also changed the course of the ...

NEW YORK -- When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer. Just one ...

One in five people who take nirmatrelvir/ritonavir (Paxlovid) get COVID-19 again after the drug clears them of it, according to a new study. For reference, people who didn’t take ...

President Joe Biden continues to test positive for COVID-19, though his symptoms are improving as he goes through the phenomenon experts refer to as a Paxlovid rebound. “Given his rebound positivity ...

The risk of a Paxlovid rebound may be higher than previously reported, according to a study published Feb. 22 in Clinical Infectious Diseases, an Oxford University Press journal. Pfizer researchers ...

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of ...

Earlier this year, hospitals eagerly embraced findings that the antiviral drug Paxlovid ™, also known as Niratrelvir-ritonavir, could battle severe COVID-19 symptoms. A study found that a five-day ...

After being diagnosed with Covid-19 last month, President Joe Biden recently tested negative for the coronavirus, only to test positive again a few days later. Biden had taken the antiviral medication ...